retatrutide triple agonist weight loss trial π¨ Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type 2 diabetes. π Mean body change at 80 weeks: β¬οΈ Lilly's triple agonist, retatrutide, delivered
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5


























